Navigation Links
Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting

eep had been significantly more refreshing than did the placebo group. At 1, 3, and 10mg, subjects felt alert and more than 87% of subjects considered their ability to concentrate as "very good" or "excellent" the morning following dosing, which was similar to the placebo group.

In this study, NG2-73 was generally well tolerated with adverse events (e.g. somnolence) attributable to the pharmacological action of the drug. There were no deaths, or drug-related serious adverse events or discontinuations, and no clinically important changes in safety laboratory reports, vital signs or electrocardiograms (ECGs).

In this study, NG2-73 was shown to be a potent sedative hypnotic which significantly reduced LPS at all doses tested, which was supported by subjective responses indicating rapid sSL. Most subjects expressed good concentration, alertness, and feeling refreshed the next morning. In this study, NG2-73 was also generally well-tolerated.

"Pharmacokinetic-Pharmacodynamic Effects of NG2-73, a Novel GABA(A) Agonist, and Zolpidem" (Phase 1)

NG2-73 is a GABA(A) receptor partial agonist which has preference for the alpha-3 subunit. In vivo animal experiments suggest that NG2-73 will have an improved side effect profile compared to zolpidem based on ethanol interaction and on assessments of learning and memory at equipotent hypnotic doses. The objectives of this study were to evaluate the relationship of dose, plasma concentration, and time to the pharmacokinetics (PK) and pharmacodynamics (PD) of NG2-73 at doses of 1, 3, 5, and 10 mg and zolpidem 10 mg versus placebo in healthy subjects.

This was a single-center, randomized, double-blind, placebo-controlled, six-way crossover study of single oral doses of NG2-73 administered to 19 healthy volunteers. Safety and tolerability were assessed, and kinetic-dynamic relationships were determined using plasma concentrations and multiple measures of PD including a visual analog scale of sedation (V
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials
2. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
3. Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting
4. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
5. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
8. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
9. Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
10. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
11. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
Post Your Comments:
(Date:9/3/2015)... and ALISO VIEJO, Calif. ... (NYSE: AGN ), a leading global pharmaceutical ... medical device company focused on developing ocular implants ... today announced that they have entered into an ... an all-cash transaction.  Under the terms of the ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) has announced ... Market - By Packaging type, Regions and Vendors - ... to their offering. The growth of ... end use industry, i.e., Medical devices industry. More innovations ... so as to be tamper evident, and child-resistant. The ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Entecavir Market, ... number of people infected with hepatitis B virus (HBV) ... among which 20-30 million suffering from chronic Hepatitis B. ... liver damage and liver cancer caused by chronic Hepatitis ...
Breaking Medicine Technology:Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8China Entecavir Market Report 2010-2019 2
... of once-daily TMC278 in ... treatment-naive adults with HIV-1 -, ... from Tibotec,Pharmaceuticals Ltd. provides additional information on the safety ... inhibitor (NNRTI), as part of HIV,combination therapy in treatment-naive ...
... CAMBRIDGE, Mass., Aug. 5 Tolerx, Inc., a,biopharmaceutical ... novel,therapies for the treatment of immune-mediated diseases, announced ... version of TRX1,MTRX1011A, an anti-CD4 monoclonal antibody, into ... patients. The clinical trial is evaluating the,safety and ...
Cached Medicine Technology:Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
(Date:9/4/2015)... ... September 04, 2015 , ... ... assistance company today announced that it has entered into a multi-year agreement with ... an agreement to bridge the link between American healthcare, Jamaican healthcare and Health ...
(Date:9/3/2015)... ... September 03, 2015 , ... TransPack Toon gives users a set of ... wipes and framing transitions in 30 different styles. Presets range from snow, underwater, forest, ... X. , TransPack Toon features 90 cartoon transitions from 30 unique styles. Editors ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... in Patient Experience Conference 2016, to be held April 13-15 at Sheraton Hotel ... hosted event bringing together the collective voices of healthcare leaders, staff, physicians, patients ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of a comprehensive survey ... and Policy Analysis has found physician leadership development training programs to be growing ... respondents said their organizations conduct some kind of physician leadership development program, another ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... graduated compression garments. However, graduated compression garments are an effective solution for reducing ... specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a unique ...
Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3
... and adolescents growing up with inflammatory bowel disease (IBD) are ... at McMaster University and the McMaster Children,s Hospital. The ... shows children and youth with the most common forms of ... lower than other children their age, and their muscle function ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, March ... pack or more a day has dropped significantly in the United ... finds. The number of people smoking less than a pack ... added the researchers, who examined national data on smoking rates from ...
... WEDNESDAY, March 16 (HealthDay News) -- College students are less ... if their parents monitor their social lives, researchers have ... parenting style and the link is stronger with the parent ... published in the March issue of the Journal of ...
... Older adults may put themselves at risk by talking on ... new study. The researchers found that adults aged 59 to ... simulated street while talking on a mobile phone, and their ... safety. Older adults on cell phones also were more likely ...
... 16, 2011An estimated nine million working-age adults57 percent of people ... uninsured in the last two years, according to the Commonwealth ... paints a bleak picture for the 43 million adults under ... a job in the past two years, finding that job ...
... of choice for treating severe malaria, according to an updated ... the antimalarial drug artesunate, which is derived from herbs used ... patients with severe malaria. Severe malaria occurs when ... associated with rarer cerebral malaria, which affects the brain and ...
Cached Medicine News:Health News:Youth with IBD are less fit than their peers: McMaster study 2Health News:Heavy Smoking Declines in U.S. 2Health News:Heavy Smoking Declines in U.S. 3Health News:Parents Can Help Prevent Problem Drinking in College Kids 2Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 2Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 3Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 4Health News:New health insurance survey: 9 million adults joined ranks of uninsured due to job loss in 2010 5Health News:Newer antimalarials more effective than quinine against severe malaria 2
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
The Liz Claiborne eyewear collection features feminine, classic, progressive friendly designs that meet the needs of today's women. The high quality frames are modern, but not trendy....
Inquire...
... inspired by the professional male who enjoys buying ... by all men especially those between the ages ... complete range of materials, shapes and colors. Classic ... the best that fashion and technology has to ...
Medicine Products: